Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × gadoterate meglumine × Clear all

Phase

Phase NA 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

Saline Solution 25 Metformin 23 Zoledronic Acid 22 Dexamethasone 21 Cytarabine 19 Cyclophosphamide 19 Bupivacaine 18 Sodium Chloride 17 Letrozole 16 Propofol 15 Vincristine 14 Morphine 14 Methotrexate 14 Dexmedetomidine 14 Fentanyl 13 Bevacizumab 13 Imiquimod 12 Doxorubicin 12 Docetaxel 12 Prednisolone 11 Oxycodone 11 Mercaptopurine 11 Cisplatin 11 Capecitabine 11 Ropivacaine 10 Rituximab 10 Prednisone 10 Granulocyte Colony-Stimulating Factor 10 Everolimus 10 Acetaminophen 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02034708 2016-12-30

REMIND

Guerbet

Phase 4 Completed

279 enrolled 9 charts

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡